# Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk

> **NCT02313584** · PHASE3 · UNKNOWN · sponsor: **Korea University** · enrollment: 464 (estimated)

## Conditions studied

- Atrial Fibrillation
- Thromboembolism

## Interventions

- **DRUG:** dabigatran
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02313584
- **Lead sponsor:** Korea University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-12
- **Primary completion:** 2016-09
- **Final completion:** 2017-09
- **Target enrollment:** 464 (ESTIMATED)
- **Last updated:** 2014-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02313584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02313584, "Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02313584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*